NEWYou can now listen to Fox News articles!
The tide has turned COVID cases, hospitalizations, and the death rate are all on the decline. For the first time since August, the U.S. is now averaging under 100,000 new daily cases.
No longer are the days of hopelessness and no tools in our arsenal to fight COVID. I recall the days early in the pandemic when all I had was oxygen, inhalers, supportive care.
But now we are blessed. We have a variety of treatments and therapeutics that can truly save lives even if we do see another surge of cases during the winter holidays as we fast approach Thanksgiving and Christmas.
The FDA is to meet October 26 to discuss pediatric vaccination safety and efficacy profile. In the meantime, Merck recently released data that its new antiviral pill Molnupiravir cut the risk of death and hospitalizations by 50 percent in
those with mild to moderate COVID.
This is incredible. The findings were so significant Merck halted its study to submit to the FDA because they know it can save lives. This is a major advance in the fight against this illness